XAMSIMCD
Market cap8.66bUSD
Dec 20, Last price
140.55EUR
1D
0.39%
1Q
-7.84%
Jan 2017
247.12%
IPO
519.16%
Name
IMCD NV
Chart & Performance
Profile
IMCD N.V. distributes, markets, and sells specialty chemicals and ingredients in the Netherlands, rest of Europe, the Middle East, Africa, North America, South America, and the Asia-Pacific. The company offers enzymes, surfactants, biocides, chelates, rheology modifiers, solubilisers, silicones, solvents, and functional additives; active pharmaceutical, agrochemicals, biopharma, excipients and formulation, nutraceuticals, and regulated synthesis; actives, UV sunscreens, rheology modifiers, thickeners, emulsifiers, emollients, elastomers, humectants, waxes, film formers, functional powders, hair styling polymers, hair conditioners, solvents, solubilizers, pigments, pearls, colorants, opacifiers, pearlisers, preservatives, antioxidants, additives, fragrances, and essential oils; and resins and binders, additives, functional fillers, and specialty solvents. It also provides taste, texture, nutrition, and function; base oil, fuel addictive, lubricants addictive, lubricants finished fluids, solvents, degreasers and fuel, compounds, and upstream, midstream and downstream oil, gas and energy; bio-based chemicals, catalysts, intermediates, monomers, organic building blocks, processing aids, reactive diluents, solvents, and surfactants. IMCD N.V. was founded in 1995 and is headquartered in Rotterdam, the Netherlands.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 4,442,642 -3.45% | 4,601,493 33.95% | 3,435,249 23.80% | |||||||
Cost of revenue | 3,472,785 | 3,653,617 | 2,747,911 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 969,857 | 947,876 | 687,338 | |||||||
NOPBT Margin | 21.83% | 20.60% | 20.01% | |||||||
Operating Taxes | 110,851 | 122,846 | 76,591 | |||||||
Tax Rate | 11.43% | 12.96% | 11.14% | |||||||
NOPAT | 859,006 | 825,030 | 610,747 | |||||||
Net income | 292,271 -6.65% | 313,081 51.05% | 207,276 72.55% | |||||||
Dividends | (135,061) | (92,229) | (58,128) | |||||||
Dividend yield | 1.50% | 1.21% | 0.52% | |||||||
Proceeds from repurchase of equity | (3,763) | (18,670) | 312,440 | |||||||
BB yield | 0.04% | 0.25% | -2.81% | |||||||
Debt | ||||||||||
Debt current | 24,743 | 60,028 | 18,017 | |||||||
Long-term debt | 1,353,708 | 748,382 | 462,338 | |||||||
Deferred revenue | 35,752 | |||||||||
Other long-term liabilities | 45,802 | 286,385 | 275,244 | |||||||
Net debt | 975,540 | 579,318 | 296,983 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 420,008 | 298,843 | 196,263 | |||||||
CAPEX | (21,239) | (21,259) | (18,717) | |||||||
Cash from investing activities | (394,587) | (255,357) | (196,132) | |||||||
Cash from financing activities | 216,974 | (20) | 4,729 | |||||||
FCF | 1,608,356 | (191,436) | 654,587 | |||||||
Balance | ||||||||||
Cash | 394,462 | 222,005 | 177,879 | |||||||
Long term investments | 8,449 | 7,087 | 5,493 | |||||||
Excess cash | 180,779 | 11,610 | ||||||||
Stockholders' equity | 684,092 | 691,489 | 473,811 | |||||||
Invested Capital | 2,866,418 | 2,630,820 | 2,128,398 | |||||||
ROIC | 31.25% | 34.67% | 30.21% | |||||||
ROCE | 30.30% | 34.32% | 30.38% | |||||||
EV | ||||||||||
Common stock shares outstanding | 56,996 | 57,028 | 57,061 | |||||||
Price | 157.55 18.33% | 133.15 -31.61% | 194.70 86.76% | |||||||
Market cap | 8,979,720 18.26% | 7,593,278 -31.65% | 11,109,777 97.76% | |||||||
EV | 9,956,664 | 8,229,978 | 11,470,012 | |||||||
EBITDA | 1,084,080 | 1,059,356 | 780,201 | |||||||
EV/EBITDA | 9.18 | 7.77 | 14.70 | |||||||
Interest | 50,002 | 27,625 | 18,536 | |||||||
Interest/NOPBT | 5.16% | 2.91% | 2.70% |